Laurus Labs Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.46 | 0.45 | 0.50 | 0.54 | 0.60 |
Long Term Debt-Equity Ratio | 0.14 | 0.16 | 0.16 | 0.13 | 0.13 |
Current Ratio | 1.34 | 1.35 | 1.27 | 1.21 | 1.10 |
Fixed Assets | 1.08 | 1.54 | 1.59 | 1.91 | 1.27 |
Inventory | 2.95 | 3.54 | 2.92 | 3.93 | 3.59 |
Debtors | 3.08 | 4.19 | 3.69 | 4.63 | 3.82 |
Interest Cover Ratio | 3.00 | 8.22 | 11.18 | 20.34 | 4.47 |
PBIDTM (%) | 16.57 | 25.94 | 27.76 | 32.23 | 20.59 |
PBITM (%) | 9.40 | 20.74 | 22.76 | 28.11 | 14.02 |
PBDTM (%) | 13.43 | 23.42 | 25.73 | 30.85 | 17.46 |
CPM (%) | 11.82 | 18.38 | 20.94 | 24.17 | 16.12 |
APATM (%) | 4.65 | 13.17 | 15.94 | 20.05 | 9.55 |
ROCE (%) | 7.34 | 21.62 | 22.71 | 37.11 | 13.86 |
RONW (%) | 5.41 | 20.43 | 24.59 | 42.23 | 15.68 |